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Abstract  
 
In the present study, the effects of intracerebroventricular (ICV) administration of normal saline 
(control), histamine, mepyramine (a histamine H1-receptor antagonist) and ranitidine (a histamine 
H2-receptor antagonist) were investigated on the formalin-induced pain in rabbits. Subcutaneous 
(SC) injection of a formalin (100 µl, 5%) solution into the ventral surface of the right hind paw 
was performed, and the time durations spent licking and biting the injected paw were measured in 
10 min blocks for 1 h. The SC injection of formalin produced a short-lasting (10 min) pain 
response. The ICV injection of histamine at doses of 25, 50 and 100 µg significantly (P < 0.05) 
decreased the time duration spent licking and biting the injected paw. Mepyramine and ranitidine, 
used alone produced no effects. The ICV pretreatments with mepyramine and ranitidine at the 
same dose of 200 µg significantly (P  <  0.05) prevented histamine (100 µg,  ICV)-induced 
antinociception. These results indicate that activation of brain histamine with ICV injection of 
exogenous histamine produces antinociception. Central histamine H1 and H2 receptors may be 
involved in the centrally administered histamine-induced antinociception in the formalin-induced 
pain in rabbits.  
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Introduction 
 
Several lines of evidence suggest that 
brain histamine may be involved in central 
perception of pain. The 
intracerebroventricular  (ICV)  injection of 
histamine  elicited  antinociceptive effects 
in hot plate, paw pressure and abdominal 
wall  constriction  tests of  nociception  in 
rats and mice.
1  In formalin test in  mice, 
both acute and tonic phases of pain were 
attenuated by centrally administered 
histamine.
2 It was found that ICV injection 
of histamine enhanced nociceptive 
threshold assessed by the Von Frey test in 
a rat model of neuropathic pain.
3 The ICV 
administration of histamine decreased the 
number of eye wipes induced by putting a 
drop of  hypertonic saline  solution on 
corneal surface in rats.
4  It is recognized 
that the action of brain histamine on pain 
modulation is mediated through histamine 
central H1, H2 and H3 receptors.
5 The ICV 
injection of H1  agonist (2-TEA: 2-
thiazolylethylamine) and antagonist 
(pyrilamine)  produced  hypernociception 
and antinociception, respectively.
6 Both H2 
agonist (4-methylhistamine) and 
antagonist (ranitidine) enhanced  the 
threshold of nociception in rats.
7  Imepip, a 
histamine  H3  receptor agonist,  attenuated 
formalin-induced pain, and peripheral and 
central pretreatments with thioperamide 
(H3-receptor antagonist) reversed the 
suppressive effect of imepip.
8  
Formalin, as a nociceptive stimulus, has 
been frequently used to study of  pain 
mechanisms in rats and mice, and 
according to these studies, a marked 
biphasic  nociceptive behavior was 
produced by small amounts (20-100 µl) of 
dilute solutions  (0.1-10%) of formalin 
applied  in various parts of body.
9,10  
However, Aloisi et al.  (1993)  reported a 
brief period of leg  lifting caused by 
formalin (100 µl, 5%) injection into the 
hind paw in rabbits.
11 In addition, a short 
(10 min) period of head movements was 
reported after subcutaneous injection of 
formalin (100 µl, 5%) in the ear skin of 
rabbits.
12  
The present study was designed to 
investigate the effects of ICV injection of 
histamine  and its H1  and H2  antagonists, 
mepyramine  and  ranitidine, respectively, 
on  pain  response induced by sub-plantar 
injection of formalin in rabbits. 
 
Materials and Methods 
 
Animals.  Thirty six healthy adult male 
New Zealand white rabbits weighing 
between 2.5-3 kg, bred in the animal house 
of the Urmia  Faculty of Veterinary 
Medicine, were individually maintained in 
standard aluminium cages (50 × 50 × 40 
cm)  under controlled temperature (21-23 
°C) on a 12 hrs light/dark cycle. They were 
fed with a commercial diet and water was 
available ad libitum. Six rabbits were used 
in each drug treatment. The Laboratory 
Animalۥs Care and Use Center of Faculty 
of Veterinary Medicine of Urmia 
University approved all procedures 
performed in this study. 
Drugs.  Histamine dihydrochloride 
(Merck, Darmstadt, Germany) at doses of 
12.5, 25, 50 and 100 µg and mepyramine 
maleate and ranitidine  hydrochloride 
(Sigma-Aldrich Co., Steinheim, Germany) 
at the same doses of 50, 100 and 200 µg 
were used in the present study. The ICV 
injections of mepyramine and ranitidine at 
the same dose of 200 µg before  ICV 
injection of histamine (100 µg) were also 
performed. All drugs were dissolved in 
normal saline  (0.9% NaCl solution, 
control) 30 min before ICV injections. 
Lateral cerebral ventricle cannulation. 
For cannulation of the lateral ventricle of 
the brain, a stainless steel guide cannula 
was surgically implanted into the left 
lateral cerebral ventricle as described 
previously.
13  In brief, each rabbit was 
anaesthetized with a mixture of 50 mg kg
-1 
ketamine (alfasan, Woerden-Holland) and 
5  mg kg
-1  xylazine  (alfasan, Woerden-
Holland) injected intramuscularly (IM).   E.Tamaddonfard /Veterinary Research Forum. 1(June, 2010)1-6  
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 Thereafter, the head of rabbit was fixed 
in a stereotaxic apparatus (Stoelting, Wood 
Lane, IL, USA). The scalp was incised and 
the skull was leveled off  around the 
bregma. A 1 mm diameter hole was drilled 
through the skull 1 mm anterior to the 
bregma and 2.5-3  mm lateral to the 
midline and a 22-gauge, 18 mm length 
stainless steel guide cannula was vertically 
inserted until cerebrospinal fluid rose in 
the cannula. The cannula was then 
anchored with dental acrylic cement 
(Acropars, Tehran, Iran) to three preplaced 
stainless steel  screws in the skull. After 
surgery, penicillin G procaine was injected 
IM  at  a  dose of 60000 IU  kg
-1, and the 
rabbit was returned to its cage.  
Drug injection. An interval of at least 10 
days was allowed between cannula 
implantation and ICV  injection of drugs. 
Drugs  were  injected  using  a  25  μl 
Hamilton’s microsyringe. The volume of 
the  drug solution  to be injected into the 
lateral ventricle was 5 μl and the injection 
was made over a period of 30  s.  Each 
rabbit received two or three treatments, 
and seven days was allowed between 
treatments. The ICV injection of histamine 
was  performed  5  min before sub-plantar 
injection of formalin. Injection of formalin 
into the ventral surface of the hind paw 
was performed 10 min after ICV injection 
of mepyramine and ranitidine. 
Induction of pain. The formalin test was 
used for the induction of pain. The rabbits 
were placed in the formalin test cages 
(50×50×45 cm) for 45 minutes. Thereafter, 
100  μl  of  formalin  (5%) solution  was 
injected SC into the ventral surface of the 
right hind paw. Control animals received 
100 μl normal saline. Licking and biting of 
injected paw was taken as a measure of the 
pain  response. The time  durations  spent 
the licking and biting of the injected paw 
were  measured  in  10 min blocks  for  a 
period of 1 hr after formalin injection.  
Verification of the cannula. During the 
surgery and before ICV  injections,  an 
efflux of the cerebrospinal fluid through 
the cannula was observed. For additional 
confirmation of the placement of the 
cannula in the lateral ventricle of the brain, 
at the end of experiments, the rabbits were 
ICV injected with 50 µl of methylene blue 
and then were deeply anaesthetized with a 
high dose  of  ether  and decapitated. The 
brains were removed and placed in  a 
formaldehyde (10%) solution. After 24 h, 
the brains were sliced into 1mm slices and 
the placement of the tip of the cannula and 
distribution of the dye in the lateral 
ventricle were visually controlled. Data 
from  rabbits  with an incorrect placement 
of the cannula were excluded from  the 
analysis. 
Statistical analysis. Data obtained from 
the subcutaneous injections of normal 
saline and formalin were analyzed using 
repeated measure ANOVA followed by 
Duncan’s test. To evaluate significance 
differences among drug-treated groups, 
one-way analysis of variance (ANOVA) 
and Duncanۥ s test were applied. In figures, 
all values are expressed as the mean ± 
S.E.M. A value of P  <  0.05 was 
considered statistically significant. 
 
Results 
 
Sub-plantar injection of normal saline 
produced a weak response of licking and 
biting of the injected paw.  After sub-
plantar injection of formalin, a significant 
(P  <  0.05) difference was observed 
between first 10 min block with other 10 
min blocks (Fig. 1). 
 
Fig 1. Time (seconds) spent of licking and biting of 
the injected paw after sub-plantar injection of 
normal saline and formalin in rabbits, *P < 0.05 as 
compared with normal saline and other 10 min 
blocks. n = 6 rabbits. E.Tamaddonfard /Veterinary Research Forum. 1(June, 2010) 1-6  
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The ICV injection of histamine at a dose 
of  12.5  μg  produced  no significant (P  > 
0.05)  effect, whereas  at doses of 25, 50 
and  100  μg,  histamine  significantly (P  < 
0.05) reduced formalin-induced pain 
response (Fig. 2). 
The ICV injection of mepyramine and 
ranitidine at doses of 50, 100 and 200 μg, 
produced no significant (P > 0.05) effect 
on the durations of licking and biting of 
the injected paw induced by formalin (Fig. 
3). 
Pretreatments with mepyramine and 
ranitidine  at  the  same  dose  of  200  μg 
significantly  (P  <  0.05) prevented 
histamine (100μg)-induced antinociception 
(Fig. 4). 
 
 
   
Fig 2. Effect of ICV injection of histamine on the 
formalin-induced pain response in rabbits, *P  < 
0.05 as compared with normal saline (control), n = 
6 rabbits for normal saline and histamine (12.5 and 
25 μg) and 6 rabbits for histamine (50 and 100 μg). 
 
 
Fig 3. Effect of ICV injections of mepyramine and 
ranitidine on the formalin-induced pain response in 
rabbits, n = 6 rabbits for mepyramine and 6 rabbits 
for ranitidine. 
 
 
 
Fig  4.  Effect of ICV pretreatments with 
mepyramine and ranitidine on the histamine-
induced antinociception in the formalin test in 
rabbits, *P < 0.05 as compared with normal saline 
plus histamine (100 μg), n = 6 rabbits for normal 
saline plus normal saline and normal  saline plus 
histamine and 6 rabbits for mepyramine plus 
histamine and ranitidine plus histamine 
 
Discussion 
 
In the present study, sub-plantar injection 
of formalin produced a monophasic pain 
response,  which lasted for 10 min. This 
finding is in agreement with those studies 
which performed for the study of pain in 
rabbits.
11, 12  
The present results  indicated  that  the 
activation of brain histamine with ICV 
injection of exogenous histamine produced 
an antinociceptive effect  in the rabbit 
model of formalin test. The cell bodies of 
histaminergic neuronal  system  are found 
only in the tuberomammillary nucleus of 
the hypothalamus, and their fibers and 
terminals  innervate the entire central 
nervous system.
14  The  areas such as the 
external layers of dorsal horn of the spinal 
cord,  preaqueductal gray  and raphe 
nucleus, known to be involved in 
nociceptive control
15  are also innervated 
by histaminergic system of 
hypothalamus.
14 Antinociceptive effects of 
brain histamine and the involvement of its 
receptors in various inflammatory models 
of pain in rodents have been investigated 
by injection of the amine into the lateral 
ventricle  or into the specific nuclei  of 
brain.  The  ICV  injection of histamine 
attenuated  formalin-induced  nociception, 
paw edema as well as  protein   E.Tamaddonfard /Veterinary Research Forum. 1(June, 2010)1-6  
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concentration in edema fluid.
16 In another 
study, centrally administered histamine 
reduced  hyperalgesia induced by 
intraplantar injection of carrageenan.
17 The 
ICV injection of histamine suppressed the 
late phase of formalin-induced pain in 
rats.
18 Microinjection of histamine into the 
dorsal hippocampus suppressed the 
formalin-induced orofacial pain in rats.
19  
In the present study, histamine H1 and H2 
antagonists  -when used alone-, did not 
change formalin-induced pain response. 
The  ICV  injection of chlorpheniramine 
alone did not affect the nociceptive 
response in the hot plate test in rats
20 
whereas in the acute corneal pain in rats, 
an antinociceptive effect induced by ICV 
injection of chlorpheniramine was 
reported.
4  The  ICV  injections of 
mepyramine and famotidine alone 
suppressed the second phase of formalin-
induced pain in rats.
18  The tricyclic 
compound, ReN 1869, a novel histamine 
H1 receptor antagonist that penetrates the 
blood-brain barrier, has been found to 
induce antinociception in chemical 
(formalin,  capsaicin and phenylquinone 
writhing) but not in thermal (hot plate and 
tail flick) tests of nociception.
21 
Microinjection of mepyramine and 
ranitidine into the hippocampus did not 
influence both phases of formalin-induced 
orofacial pain in rats.
19 
In this study, both H1 and H2 antagonists 
prevented histamine-induced 
antinociception. This indicates that both 
histamine H1  and H2  receptors may be 
involved in the antinociceptive effect 
induced by histamine. The histamine H1 
and H2  receptors play important roles  in 
both somatic and visceral nociception 
because histamine H1  and H2  receptors 
knockout mice showed fewer nociceptive 
responses in various pain tests.
22, 23  It was 
found that intracerebral microinjection of 
temelastine (H1-receptor antagonist) and 
cimetidine into the periaqueductal gray or 
into the raphe nucleus  prevented the 
histamine-induced antinociception.
24 
Moreover, using tail flick and paw 
pressure tests, the antinociceptive effect 
induced by  SKF 91488, an inhibitor of 
histamine catabolism, was prevented by 
chlorpheniramine pretreatment.
20  In a rat 
model of acute trigeminal pain, the 
preventive effect of ranitidine, but not 
chlorpheniramine on the histamine-
induced antinociception was reported.
4 
The  ICV  pretreatments with 
chlorpheniramine and ranitidine prevented 
histamine-induced antinociception in 
rats.
18  In the rat model of orofacial 
formalin-induced pain, microinjection of 
mepyramine and ranitidine into the dorsal 
hippocampus prevented histamine-induced 
antinociception.
19 The differences between 
the findings  may be associated with the 
nature and  sensitivity of the 
experimentally induced pain models the 
kind of histamine H1  and H2  receptor 
blockers used applied. 
In conclusion, the present results suggest 
that the activation of brain histamine with 
ICV  injection of exogenous histamine 
produces an antinociceptive effect in the 
formalin-induced pain in rabbits. 
Moreover, central histamine H1  and H2 
receptors may be involved in the 
antinociception induced by centrally 
administered histamine. 
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